Merck, Pfizer Pneumococcal Vaccines: More Serotype Protection Vs. Pneumonia Indication

 
• By Brenda Sandburg

Ahead of CDC advisory committee this fall, Merck highlights additional bacteria serotypes its Vaxneuvance protects against while Pfizer touts Prevnar 13’s indication for pneumonia.

pneumococcal vaccine
Merck and Pfizer tout the value of their pneumococcal vaccines to analysts. • Source: Alamy

More from US FDA Performance Tracker

More from Regulatory Trackers